These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22173146)

  • 21. Safety of second-generation rotavirus vaccines, intussusception.
    Vázquez M
    Curr Opin Pediatr; 2014 Feb; 26(1):101-5. PubMed ID: 24335963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of intussusception after monovalent rotavirus vaccination.
    Weintraub ES; Baggs J; Duffy J; Vellozzi C; Belongia EA; Irving S; Klein NP; Glanz JM; Jacobsen SJ; Naleway A; Jackson LA; DeStefano F
    N Engl J Med; 2014 Feb; 370(6):513-9. PubMed ID: 24422678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure Studies.
    Rosillon D; Buyse H; Friedland LR; Ng SP; Velázquez FR; Breuer T
    Pediatr Infect Dis J; 2015 Jul; 34(7):763-8. PubMed ID: 26069948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. More on RotaShield and intussusception: the role of age at the time of vaccination.
    Simonsen L; Viboud C; Elixhauser A; Taylor RJ; Kapikian AZ
    J Infect Dis; 2005 Sep; 192 Suppl 1():S36-43. PubMed ID: 16088803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus infection and intussusception in Tunisian children: implications for use of attenuated rotavirus vaccines.
    Chouikha A; Fodha I; Maazoun K; Ben Brahim M; Hidouri S; Nouri A; Trabelsi A; Steele AD
    J Pediatr Surg; 2009 Nov; 44(11):2133-8. PubMed ID: 19944222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of history of intussusception as a contraindication for rotavirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1427. PubMed ID: 22012117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RotaTeq vaccine adverse events and policy considerations.
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
    Bines JE; Patel M; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine.
    Vesikari T; Karvonen A; Ferrante SA; Kuter BJ; Ciarlet M
    Pediatr Infect Dis J; 2010 Oct; 29(10):957-63. PubMed ID: 20442684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in Korea.
    Kim KY; Kim DS
    Yonsei Med J; 2017 May; 58(3):631-636. PubMed ID: 28332371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014.
    Haber P; Parashar UD; Haber M; DeStefano F
    Vaccine; 2015 Sep; 33(38):4873-7. PubMed ID: 26276687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
    Dennehy PH; Goveia MG; Dallas MJ; Heaton PM
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S36-42. PubMed ID: 18162245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
    Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
    Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India.
    John J; Kawade A; Rongsen-Chandola T; Bavdekar A; Bhandari N; Taneja S; Antony K; Bhatnagar V; Gupta A; Kabra M; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A104-9. PubMed ID: 25091662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Underestimates of intussusception rates among US infants based on inpatient discharge data: implications for monitoring the safety of rotavirus vaccines.
    Cortese MM; Staat MA; Weinberg GA; Edwards K; Rice MA; Szilagyi PG; Hall CB; Payne DC; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S264-70. PubMed ID: 19817607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):577-81. PubMed ID: 10428095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine discontinuation and switching following regulatory interventions in response to rotavirus vaccine contamination with porcine circovirus DNA fragments.
    Dore DD; Turnbull BR; Seeger JD
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):415-9. PubMed ID: 22290786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.